Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene

被引:97
作者
Kalea, Anastasia Z. [1 ]
Reiniger, Nina [1 ]
Yang, Hojin [1 ]
Arriero, Maria [1 ]
Schmidt, Ann Marie [1 ]
Hudson, Barry I. [1 ]
机构
[1] Columbia Univ, Dept Surg, Coll Phys & Surg, Div Surg Sci, New York, NY 10032 USA
基金
美国国家卫生研究院;
关键词
DNA cloning; mRNA; soluble receptor; species-specific splicing; protein evolution; CELL-SURFACE RECEPTOR; SOLUBLE RECEPTOR; CYTOPLASMIC DOMAIN; NEURITE OUTGROWTH; PLASMA-LEVELS; HUMAN BRAIN; EXPRESSION; ATHEROSCLEROSIS; DISEASE; ACTIVATION;
D O I
10.1096/fj.08-117739
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The alternative splicing of pre-mRNAs is a critical mechanism in genomic complexity, disease, and development. Studies of the receptor for advanced glycation end-products (RAGE) indicate that this gene undergoes a variety of splice events in humans. However, no studies have extensively analyzed the tissue distribution in other species or compared evolutionary differences of RAGE isoforms. Because the majority of studies probing RAGE function have been performed in murine models, we therefore performed studies to identify and characterize the splice variants of the murine RAGE gene, and we compared these to human isoforms. Here, using mouse tissues, we identified numerous splice variants including changes in the extracellular domain or the removal of the transmembrane and cytoplasmic domains, which produce soluble splice isoforms. Comparison of splice variants between humans and mice revealed homologous regions in the RAGE gene that undergo splicing as well as key species-specific mechanisms of splicing. Further analysis of tissue splice variant distribution in mice revealed major differences between lung, kidney, heart, and brain. To probe the potential impact of disease- like pathological states, we studied diabetic mice and report that RAGE splice variation changed dramatically, resulting in an increase in production of soluble RAGE (sRAGE) splice variants, which were not associated with detectable levels of sRAGE in murine plasma. In conclusion, we have determined that the murine RAGE gene undergoes extensive splicing with distinct splice isoforms being uniquely distributed in different tissues. These differences in RAGE splicing in both physiological and pathogenic states further expand our understanding of the biological repertoire of this receptor in health and disease.-Kalea, A. Z., Reiniger, N., Yang, H., Arriero, M., Schmidt, A. M., Hudson, B. I. Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. FASEB J. 23, 1766-1774 (2009)
引用
收藏
页码:1766 / 1774
页数:9
相关论文
共 41 条
[1]
Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein [J].
Basta, Giuseppina ;
Sironi, Anna Maria ;
Lazzerini, Guido ;
Del Turco, Serena ;
Buzzigoli, Emma ;
Casolaro, Arturo ;
Natali, Andrea ;
Ferrannini, Ele ;
Gastaldelli, Amalia .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4628-4634
[2]
Assay validation and biological variation of serum receptor for advanced glycation end-products [J].
Brown, Louise F. ;
Fraser, Callum G. .
ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 :518-519
[3]
Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain [J].
Ding, QX ;
Keller, JN .
NEUROSCIENCE LETTERS, 2005, 373 (01) :67-72
[4]
Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia [J].
Emanuele, E ;
D'Angelo, A ;
Tomaino, C ;
Binetti, G ;
Ghidoni, R ;
Politi, P ;
Bernardi, L ;
Maletta, R ;
Bruni, AC ;
Geroldi, D .
ARCHIVES OF NEUROLOGY, 2005, 62 (11) :1734-1736
[5]
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men [J].
Falcone, C ;
Emanuele, E ;
D'Angelo, A ;
Buzzi, MP ;
Belvito, C ;
Cuccia, M ;
Geroldi, D .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) :1032-1037
[6]
Calcium-regulated intramembrane proteolysis of the RAGE receptor [J].
Galichet, Arnaud ;
Weibel, Mirjarn ;
Heimann, Claus W. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 370 (01) :1-5
[7]
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension [J].
Geroldi, D ;
Falcone, C ;
Emanuele, E ;
D'Angelo, A ;
Calcagnino, M ;
Buzzi, MP ;
Scioli, GA ;
Fogari, R .
JOURNAL OF HYPERTENSION, 2005, 23 (09) :1725-1729
[8]
Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice [J].
Goova, MT ;
Li, J ;
Kislinger, T ;
Qu, W ;
Lu, Y ;
Bucciarelli, LG ;
Nowygrod, S ;
Wolf, BM ;
Caliste, X ;
Yan, SF ;
Stern, DM ;
Schmidt, AM .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (02) :513-525
[9]
Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE) [J].
Hanford, LE ;
Enghild, JJ ;
Valnickova, Z ;
Petersen, SV ;
Schaefer, LM ;
Schaefer, TM ;
Reinhart, TA ;
Oury, TD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (48) :50019-50024
[10]
Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression [J].
Harashima, Ai ;
Yamamoto, Yasuhiko ;
Cheng, Chunmei ;
Tsuneyama, Koichi ;
Myint, Khin Mar ;
Takeuchi, Akihiko ;
Yoshimura, Kazunobu ;
Li, Hui ;
Watanabe, Takuo ;
Takasawa, Shin ;
Okamoto, Hiroshi ;
Yonekura, Hideto ;
Yamamoto, Hiroshi .
BIOCHEMICAL JOURNAL, 2006, 396 :109-115